Milestone Pharmaceuticals's total assets for Q4 2024 were $75.50M, a decrease of -8.71% from the previous quarter. MIST total liabilities were $62.35M for the fiscal quarter, a 6.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.